04-Jan-2012 By Gareth Macdonald
Supply chain security group Rx-360 has warned that guar gum – a thickening agent that is widely used in the drug industry – is in short supply.
04-Jan-2012 By Gareth Macdonald
GSK CEO Andrew Witty has been knighted in the Queen's New Year Honours list in recognition of his services to the UK economy and pharmaceutical industry.
04-Jan-2012 By Nick Taylor
The Indian pharmaceutical industry faces “intense competition” from China as it tries to grow exports to $25bn, the country's commerce minister said.
Shasun’s Cuddalore plant operations still on hold after cyclone
03-Jan-2012 By Gareth Macdonald
Manufacturing operations at Shasun Pharma’s plant in Cuddalore, Tamil Nadu are still suspended days after Southern India was battered by a cyclonic storm.
22-Dec-2011 By Gareth Macdonald
Pall will buy US instrument maker ForteBio next year in a continuation of efforts to build its biomanufacturing technology offering.
21-Dec-2011 By Gareth Macdonald
Lonza has expanded small molecule production capacity at its plant in Nansha, China to meet demand for clinical trial materials.
SE Asia likely source of fake anti-malarials in Africa; study
20-Dec-2011 By Nick Taylor
Counterfeit anti-malarials containing the Viagra API were probably manufactured in Southeast Asia, researchers found.
20-Dec-2011 By Gareth Macdonald
DSM Biologics will work with the Australian Institute for Bioengineering and Nanotechnology (AIBN) on the commercialisation of development-stage biologics projects.
19-Dec-2011 By Gareth Macdonald
New Asian CRO Alliance (ACA) can offer faster and better decision making than multinational CROs says Semler Research Centre's clinical development VP.
19-Dec-2011 By Gareth Macdonald
GE Healthcare wont say if its new turnkey biologics plant development service will offer Governments in emerging nations discounted rates.
15-Dec-2011 By Gareth Macdonald
Six Asian CROs have set up a regional network and claim their local knowledge will make conducting clinical trials in the region more straightforward.
15-Dec-2011 By Nick Taylor
Charles River wants to buy drug discovery assets to meet interest in strategic outsourcing of non-regulated efficacy testing.
14-Dec-2011 By Gareth Macdonald
GE Healthcare and M+W Group aim to capture a share of the rapidly expanding global biologics market with a new plant and manufacturing tech partnership.
14-Dec-2011 By Natalie Morrison
Quintiles hopes to build up its China-based study portfolio through its new contract research organisation (CRO) Kun Tuo.
AZ buys Chinese generics manufacturer
12-Dec-2011
UK drug maker AstraZeneca has bought Chinese non-branded drugmaker Guangdong BeiKang Pharma.
Icon continues investment spree with China buy
update
12-Dec-2011 By Gareth Macdonald
Ireland-based CRO Icon says acquisition of Chinese trial firm BeijingWits Medical Consulting will boost capabilities in the country and help meet growing demand from global clients.
Almac and Marken launch trial supply solutions
07-Dec-2011 By Gareth Macdonald
Clinical supply chains dominated the concerns of the service sector this week with Almac and Marken both launching new management solutions.
Bosch lauds new extrusion and calendaring line’s API solubility benefits
07-Dec-2011 By Gareth Macdonald
Bosch Packaging Technology says melt extrusion is the answer to drug manufacturers’ active pharmaceutical ingredient (API) solubility questions.
Samsung and Quintiles' biosimilars JV teams with Biogen Idec
06-Dec-2011 By Gareth Macdonald
Samsung will set up a $300m biosimilars development JV with Massachusetts, US-based Biogen Idec, building on the partnership it forged with CRO Quintiles earlier this year.
Ethiopian quality control lab gains ISO testing accreditation
05-Dec-2011 By Nick Taylor
The Ethiopian national quality control laboratory has gained ISO accreditation to improve access to safe medicines.
05-Dec-2011 By Gareth Macdonald
The global contract manufacturing market may be showing signs of recovery but careful investment and focusing on core activities is still the most sensible approach according to Sweden-based CDMO Recipharm.
Rise of Asian biopharm creates investment targets for Quintiles
01-Dec-2011 By Nick Taylor
Quintiles expects to make more investments in Asia-Pacific partnerships as the local biopharm sector grows.
China-focused USP committee to develop excipient standards
29-Nov-2011 By Nick Taylor
USP is creating a China-focused East Asia expert committee to develop quality standards for excipients.
Russian rules on local trials blow for drug sector and boon for unethical CROs
28-Nov-2011 By Gareth Macdonald
The requirement for local clinical trials has been a ‘serious blow’ to Russia’s drug approval system and an opportunity for unethical CROs according to the Moscow-based Association of Clinical Trial Organisations (ACTO).
Indian trial compensation guidelines open to comment
28-Nov-2011 By Nick Taylor
India is seeking comments on draft guidelines that detail sponsors’ clinical trial injury compensation responsibilities.
FDA anti-adulteration efforts hindered by industry; GAO
28-Nov-2011 By Nick Taylor
Industry reluctance to share information on economic adulteration is hindering FDA efforts to tackle tainted ingredients, a GAO report found.
Take Solutions inks Mene deal for emerging market services
24-Nov-2011 By Alexandria Pesic
Take Solutions has partnered with Turkish CRO Mene Research to offer drug safety services in emerging markets.
FDA sends Mylan Puerto Rico plant a GMP warning letter
23-Nov-2011 By Nick Taylor
The US FDA has sent Mylan a warning letter after inspectors found GMP testing failings at its Puerto Rico facility.
Schott strikes deal with Xinkang for joint venture in China
22-Nov-2011 By Alexandria Pesic
German technology giant Schott has signed an agreement with a Chinese firm to provide the fast-growing pharmaceutical market with a range of high-end glass packaging products.
ShangPharma opening facility dedicated to major customer
22-Nov-2011 By Nick Taylor
ShangPharma is opening a 100,000 sq ft facility dedicated to serving a big customer as it continues to strengthen ties to top clients.
Aanjaneya’s profit soars as post-IPO expansion continues
17-Nov-2011 By Nick Taylor
Net profit at Indian API and formulation business Aanjaneya Lifecare jumped as it enacted post-IPO expansion plans to ‘dominate’ its markets.
UCB inks deal with Parexel & PRA to boost cost-effectiveness
16-Nov-2011 By Nick Taylor
UCB has inked a strategic deal with Parexel and PRA that an analyst believes has “very favourable” terms for the biopharm.
USP forges closer ties with Chilean drug standards group
15-Nov-2011 By Gareth Macdonald
The USP has forged closer bonds with the Chilean Pharmacopoeia Foundation (CPF) in the latest of a series of agreements with regional drug quality groups.
Trust in drug source may blind wholesalers to counterfeits
15-Nov-2011 By Nick Taylor
Wholesalers’ trust in the quality of products from some countries could decrease vigilance and allow counterfeits to reach pharmacies, research found.
Pall sets up Singapore processing COE
14-Nov-2011
Processing technology maker Pall has opened a new centre of excellence in Singapore in a bid to capture a share of the country’s growing biomanufacturing sector.
inVentiv sets up in Korea as outsourcing demand grows
14-Nov-2011 By Nick Taylor
inVentiv Health has set up in Korea to meet growing demand for clinical and commercial services in the country.
K-V prompts FDA investigation into compounding pharmacies
09-Nov-2011 By Nick Taylor
The FDA is investigating compounding pharmacies’ Makena after K-V Pharmaceutical said they differ from approved forms.
Globalised supply chain drives EMA to rethink batch release
09-Nov-2011 By Nick Taylor
The EMA plans to update guidance on certification and batch release in response to globalisation of the pharma supply chain.
Pharma CSR reporting up 39% in 2011 according to KPMG
09-Nov-2011
Pharma sector corporate social responsibility (CSR) reporting has increased dramatically in recent years according to a new report that argues such activity enhances financial value.
Cyprotex invests to meet demand for cell-based preclinical tox
08-Nov-2011 By Gareth Macdonald
Cyprotex says increasing demand for cell-based preclinical toxicology services in North America prompted facility expansion plan.
Chinese FDA should hire CMC staff to boost QbD; Pfizer exec
08-Nov-2011 By Nick Taylor
The Chinese FDA should hire more CMC reviewers to encourage QbD applications, a Pfizer executive said.
Decline in Russian trial approvals slows in Q3
07-Nov-2011 By Gareth Macdonald
New data suggests the Russian MoH is getting faster at reviewing and approving clinical trials.
Greater FDA inspection role increased drug recalls in Q3, study
07-Nov-2011 By Gareth Macdonald
Greater FDA oversight of US manufacturing plants increased the number of drug recalls in Q3 in a trend that is likely to continue according to a new report.
07-Nov-2011 By Nick Taylor
Catalent is considering acquisitions as it adds scale, drug delivery technologies and capacity in emerging markets.
ViiV teams with Russian manufacturer
03-Nov-2011 By Gareth Macdonald
ViiV, GSK and Pfizer’s HIV joint venture, has partnered with Russia’s JSC Binnopharm to boost manufacturing capacity in the country.
Lonza’s CMO biz gains pegged back by higher raw materials costs for ingredients unit
02-Nov-2011 By Gareth Macdonald
Gains made in manufacturing, particularly in biologics, were pegged back by the impact raw materials costs and the strong Franc had on its ingredients division says Lonza.
Gentronix partners to add cell health assays for early research
02-Nov-2011 By Nick Taylor
Gentronix has added cell health assays through a partnership with BioQuanta to detect toxicity earlier in development.
31-Oct-2011 By Gareth Macdonald
CMO Aenova says demand for contract manufacturing capacity in Europe is increasing.
Effective outsourcers will have competitive edge in 2020; KPMG
26-Oct-2011 By Nick Taylor
Effectively outsourcing a significant portion of work will give biopharm a competitive advantage in 2020, KPMG said.
Quintiles says payers driving demand for market access offering
25-Oct-2011 By Gareth Macdonald
US CRO Quintiles says healthcare payer influence is driving pharmaceutical industry demand for market access services.
